Smoking and lower extremity artery disease.
Study Goal
The researchers aimed to highlight the harmful effects of smoking on lower extremity arterial disease (LEAD) and emphasize the importance of smoking cessation interventions in medical management.
Results Summary
Smoking is strongly associated with LEAD progression, worse post-procedural outcomes, and increased healthcare utilization due to mechanisms like endothelial dysfunction, oxidative stress, and inflammation. Smoking cessation is critical for LEAD patients, but interventions remain underutilized.
Population
Patients with lower extremity arterial disease (LEAD).
Effective Dosage
Not Assessed
Duration
Not Assessed
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Cigarette smoking | increase | lower extremity arterial disease (LEAD) | - | - | is a major preventable risk factor for | #1 |
Cigarette smoking | increase | disease progression | - | - | is strongly associated with a higher risk of | #2 |
Cigarette smoking | increase | worse post-procedural outcomes | - | - | is strongly associated with | #3 |
Cigarette smoking | increase | increased healthcare utilization | - | - | is strongly associated with | #4 |
Smoking | increase | atherosclerotic | - | - | provokes the development of | #5 |
Smoking cessation | neutral | - | patients with LEAD | - | are mandatory | #6 |
smoking cessation methods, including pharmacological treatment | neutral | - | - | - | are mandatory | #7 |
smoking cessation treatments | neutral | - | medical management of LEAD | - | highlight the importance of incorporating | #8 |
Regulatory approaches to reduce tobacco use and support smoking cessation | decrease | LEAD | - | - | have the potential to reduce the burden of | #9 |
Cigarette smoking is a major preventable risk factor for lower extremity arterial disease (LEAD) and is strongly associated with a higher risk of disease progression, worse post-procedural outcomes, and increased healthcare utilization. Smoking provokes the development of atherosclerotic through different mechanisms. Endothelial cell dysfunction, oxidative stress, inflammation, and arterial stiffness are among the key factors related to the development of atherogenesis due to smoking. Smoking cessation among patients with LEAD and the use of smoking cessation methods, including pharmacological treatment, are mandatory. Given that smoking cessation interventions remain underutilized. Therefore, in this narrative review we highlight the importance of incorporating smoking cessation treatments as part of the medical management of LEAD. Regulatory approaches to reduce tobacco use and support smoking cessation have the potential to reduce the burden of LEAD.